.png)
Sempulse, an innovative medical device manufacturer, will relocate its headquarters to the Science Technology and Advanced Research (STAR) Park at Texas State University.
The move will allow Sempulse to expand its presence in Austin and San Antonio, making San Marcos a perfect hub, and provides the opportunity to leverage Texas State faculty and students as a resource for developing new offering.
STAR Park is Texas State’s 58-acre research park dedicated to collaboration with industry, government laboratories and nonprofit research institutions to accelerate innovation, commercialization and entrepreneurship in the Texas Innovation Corridor.
“STAR Park provides the unique opportunity to leverage the resources and support provided by Texas State University as well as allowing us to have access to partners in San Antonio and Austin, making STAR Park the ideal location for Sempulse,” said Sempulse CEO Kurt Stump.
Due to their work in the triage space, Sempulse has had considerable support and backing from the Department of Defense. The company is also currently expanding into a number of other areas: enhancing peak performance training for athletes, utilizing cloud services to connect physicians, patients and field personnel, providing better telemedicine services to rural and remote areas, monitoring rehabilitation and outpatient services for chronic diseases as well as optimizing health outcomes through machine learning.
“Sempulse is on a mission to change the healthcare industry as we know it and we’re excited for STAR Park to be a part of their journey,” said STAR Park Executive Director Stephen Frayser.
About STAR Park
STAR Park serves as a catalyst for collaboration supporting Texas State’s goal of becoming eligible for distributions from the National Research University Fund by growing the regional ecosystem through activities promoting and supporting commercialization, entrepreneurship and innovation. For more information please visit the STAR Park website at Texas State's website.
About Sempulse
Sempulse is a medical device manufacturer. They have developed a patented, noninvasive vital signs sensor that adheres to the back of the ear and acquires patients’ five major vital signs. This is industry-first cuffless blood pressure, pulse oximetry, heart rate, respiratory rate and core body temperature, plus geolocation and a wealth of environmental information. While designed for austere and rugged military needs, the technology is equally capable in the civilian world. For more information about Sempulse, visit Sempulse's website, or email [email protected].
